12 studies found for:    weill | Open Studies | "Stomach Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis
Intervention:
2 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
3 Recruiting FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Gastric Adenocarcinoma;   Gastric Cancer
Interventions: Procedure: FDG-PET;   Procedure: surgery;   Drug: 5-FU;   Drug: capecitabine;   Drug: docetaxel;   Drug: Irinotecan;   Radiation: 3D-CRT;   Radiation: IMRT
4 Recruiting Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma;   Gastric Cancer
Interventions: Drug: Docetaxel, Leucovorin, Fluorouracil, Cisplatin;   Drug: Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen
5 Unknown  Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer
Conditions: Esophageal Cancer;   Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions: Drug: Azacitidine;   Drug: Oxaliplatin;   Drug: Epirubicin;   Drug: Capecitabine
6 Recruiting Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")
Condition: Gastric Cancer
Intervention:
7 Recruiting Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors
Conditions: Solid Tumors;   Gastric Cancer
Intervention: Drug: FPA144
8 Recruiting A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
Conditions: Gastric Cancer;   Gastroesophageal Junction Cancer
Interventions: Drug: BBI608;   Drug: Paclitaxel;   Other: Placebo
9 Recruiting Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
Conditions: Pancreatic Tumor;   Gastric Tumor;   Esophageal Tumor;   Lymphadenopathy;   Duodenal Tumor
Intervention: Procedure: Endoscopic ultrasound guided needle tissue acquisition.
10 Unknown  Changes Associated With H. Pylori and Gastric Carcinogenesis
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Intervention: Procedure: Endoscopy tissue collection
11 Recruiting A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
Conditions: Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma
Interventions: Drug: Ramucirumab;   Drug: Paclitaxel
12 Recruiting GS-5745 With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Condition: Gastric Adenocarcinoma
Interventions: Drug: GS-5745;   Drug: GS-5745 Placebo;   Drug: Leucovorin;   Drug: 5-fluorouracil;   Drug: Oxaliplatin

Indicates status has not been verified in more than two years